Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Salwen

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Molecular Cancer Therapeutics|January 25, 2019
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for NeuroblastomaAlexandre Chlenski, Chanyoung Park, Marija Dobratic, et al.
Oncotarget|October 22, 2016
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patientsMark A Applebaum, Aashish R Jha, Clara Kao, et al.
JCO Precision Oncology|June 11, 2019
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor PhenotypeMark A Applebaum, Erin K Barr, Jason Karpus, et al.
Cancer Research|July 21, 2012
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastomaKelly R Ostler, Qiwei Yang, Timothy J Looney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with NeuroblastomaMark A Applebaum, Erin K Barr, Jason Karpus, et al.
Molecular Oncology|February 25, 2014
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ systemThomas P Stricker, Andres Morales La Madrid, Alexandre Chlenski, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Molecular Cancer Therapeutics|January 25, 2019
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for NeuroblastomaAlexandre Chlenski, Chanyoung Park, Marija Dobratic, et al.
Oncotarget|October 22, 2016
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patientsMark A Applebaum, Aashish R Jha, Clara Kao, et al.
JCO Precision Oncology|June 11, 2019
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor PhenotypeMark A Applebaum, Erin K Barr, Jason Karpus, et al.
Cancer Research|July 21, 2012
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastomaKelly R Ostler, Qiwei Yang, Timothy J Looney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with NeuroblastomaMark A Applebaum, Erin K Barr, Jason Karpus, et al.
Molecular Oncology|February 25, 2014
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ systemThomas P Stricker, Andres Morales La Madrid, Alexandre Chlenski, et al.
Pageof 5